Clinical Trial: A Pharmacokinetic Study of SHR8554 Injection in the Population With Renal Insufficiency and Healthy Participants

U.S., Sept. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07189962) titled 'A Pharmacokinetic Study of SHR8554 Injection in the Population With Renal Insufficiency and Healthy Participants' on Sept. 17.

Brief Summary: The study is being conducted to evaluate the safety and pharmacokinetic characteristics of SHR8554 injection in subjects with renal insufficiency and healthy subjects.

Study Start Date: Sept. 20, 2022

Study Type: INTERVENTIONAL

Condition: Moderate to Severe Postoperative Pain

Intervention: DRUG: SHR8554 Injection

SHR8554 injection.

Recruitment Status: COMPLETED

Sponsor: Jiangsu HengRui Medicine Co., Ltd.

Published by HT Digital Content Services with permission from Health Daily Dige...